In the present study, treatment of CXCL1-overexpressing colon cancer cells with C646 (an inhibitor of P300) led to inhibition of CXCL1 expression along with decrease in the protein level of p65 in the nucleus. This evidence concerns the gene CXCL1 and colonic neoplasm.